Mendas Pharma Private Limited, a active private limited company, was established on 11 December 2019 in Vile Parle East,Mumbai, Maharashtra, India. Engaging in drug formulation & development within the pharma sector, it holds CIN: U24100MH2019PTC334311. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹10.00 Cr and a paid-up capital of ₹10.00 Cr.
Employing 37 professional, Its leadership includes Umesh Mavjibhai Mendapara (Director), Parth Vinodkumar Mendpara (Director), Harsh Bhupat Mendpara (Director). Past directors included Alpeshkumar Thakarshibhai Mendapara, Shailesh Babubhai Mendpara, Sanjay Mavjibhai Mendpara. It holds ₹78.00 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 1204, Vireshwar Heights, Kankuwadi Near Hanuman Temple, Phirojshah Mehta Rd, Vile Parle East,Mumbai, Maharashtra, 400057.
U24100MH2019PTC334311
334311
11 December 2019
₹10.00 Cr
₹10.00 Cr
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Mendas Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Umesh Mavjibhai Mendapara | Director | 11 Dec 2019 | Current |
| Parth Vinodkumar Mendpara | Director | 11 Dec 2019 | Current |
| Harsh Bhupat Mendpara | Director | 29 Jun 2021 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | - | Past |
| Pramod Abcsdd | Director | - | Past |
| Pramod Abcsdd | Director | - | Past |
| Pramod Abcsdd | Director | - | Past |
| Pramod Abcsdd | Director | - | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Mendas Pharma Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 112.07% increase. The company also saw a substantial improvement in profitability, with a 105.75% increase in profit. The company's net worth moved up by a moderate rise of 0.36%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
In 2023, Mendas Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹780,000,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 10 May 2021 | Others | ₹39.00 Cr | Open |
| 10 May 2021 | Others | ₹39.00 Cr | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Mendas Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Mendas Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Mendas Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Mendas Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
Mendas Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was recorded as a recent event.
Progress on Harsh Bhupat Mendpara was appointed as a Director was appointed as a Director on 29 Jun 2021 & has been associated with this company since 4 years 5 months . was documented.
Progress on A charge with Others amounted to Rs. 39.00 Cr with Charge ID 100450349 was registered on 10 May 2021. was documented.
A charge with Others amounted to Rs. 39.00 Cr with Charge ID 100450347 was registered on 10 May 2021. was recorded as a recent event.
Progress on Umesh Mavjibhai Mendapara was appointed as a Director was appointed as a Director on 11 Dec 2019 & has been associated with this company since 6 years 14 days . was documented.
The CIN of Mendas Pharma Private Limited is U24100MH2019PTC334311.
Mendas Pharma Private Limited is headquartered at 1204, Vireshwar Heights, Kankuwadi Near Hanuman Temple, Phirojshah Mehta Rd, Vile Parle East,Mumbai, Maharashtra, 400057.
Mendas Pharma Private Limited was incorporated on 11 December 2019.
The current directors of Mendas Pharma Private Limited are
The primary industry of Mendas Pharma Private Limited is Pharma.
Mendas Pharma Private Limited is unlisted.
The authorized capital of Mendas Pharma Private Limited is ₹10.00 Cr, and the paid-up capital is ₹10.00 Cr.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX